Camurus CEO Fredrik Tiberg on Long-Acting Opioid Treatment
Turning Generics Into Game-Changing Therapies: Fredrik Tiberg of Camurus Explains the Power of Long-Acting Medicines...
Fredrik Tiberg, Camurus 🇸🇪 | Opioid Crisis, Long-Acting Injections | E51
Founded in 1991, Camurus has grown into a $4B biotech with two products in the...
Why AI in Biopharma Didn’t Live Up to the Hype
AI has reshaped entire industries, from software development to entertainment, yet its impact in healthcare...
Alex Zhavoronkov, Insilico Medicine | AI Drug Development, Longevity | E39
We chat about longevity with Alex Zhavoronkov, CEO and founder of the artificial intelligence (AI)...
